Source: New York Times
Date: February 21, 2008
Summary:
The New York Times reports Novcell, Inc., used embryonic stem cells to successfully treat diabetes in mice:
"Scientists reported on Wednesday that they were able to control diabetes in mice by harnessing human embryonic stem cells. The work raised the prospect that the embryonic cells might one day be used to provide insulin-producing replacement cells to treat the disease in people. The scientists, at the biotechnology company Novocell, turned the stem cells into cells that produced insulin in the mice. Those cells kept blood sugar in check after the mice’s own insulin-producing cells were destroyed."
